ENvizion Medical Ltd. / Fundamentals

    Income statement

    Net revenue
    €2.26M
    Cost of goods sold
    €4.03M
    Gross profit
    -€1.77M
    SG&A expenses
    €15.59M
    R&D expenses
    €7.82M
    EBITDA
    -€24.41M
    D&A
    €833.05K
    EBIT
    -€25.25M
    Interest expenses
    €0.00
    EBT
    -€21.95M
    Tax expenses
    €33.99K
    Net income
    -€21.99M

    Cash flow statement

    Net deferred tax
    -€1.39M
    Non-cash items
    €149.62K
    Changes in working capital
    €1.09M
    Operating cash flow
    -€20.81M
    Capex
    €783.39K
    Other investing cash flow
    -€24.31K
    Net investing cash flow
    -€807.69K
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €0.00
    Debt repayment
    €0.00
    Other financing cash flow
    €14.93M
    Net financing cash flow
    €14.93M
    Foreign exchange effects
    -€168.05K
    Net change in cash
    -€6.85M
    Cash at end of period
    -€416.59K
    Free cash flow
    -€20.02M

    Balance sheet

    Cash and cash equivalents
    €89.04K
    Cash and short-term investments
    €184.45K
    Total receivables
    €359.35K
    Inventory
    €3.12M
    Other current assets
    €508.82K
    Total current assets
    €4.17M
    Property, plant & equipment
    €3.44M
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    -€3.44M
    Total non-current assets
    €3.44M
    Total assets
    €7.61M
    Accounts payable
    €2.47M
    Short-term debt
    €0.00
    Other current liabilities
    €7.59M
    Total current liabilities
    €10.06M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €0.00
    Total liabilities
    €13.97M
    Common stock
    €25.44K
    Retained earnings
    -€92.87M
    Other equity
    €0.00
    Total equity
    -€6.37M
    Total liabilities and shareholders' equity
    €7.61M

    Company information

    Market capitalization
    €139.02M
    Employees
    28
    Enterprise Value
    €37.93M

    Company ratios

    Gross margin
    -78.1%
    EBITDA margin
    -1,078.1%
    EBIT margin
    -1,114.9%
    EBT margin
    -969.5%
    Net margin
    -971.0%
    ROE
    345.3%
    ROA
    -289.0%
    Asset turnover
    29.8%
    FCF margin
    -953.4%
    FCF yield
    -15.5%
    Efficiency ratio
    1,178.1%
    Net sales per employee
    €80.87K
    Net income per employee
    -€785.25K

    Notifications